As of May 2024 Evolent Health has a market cap of $2.64 Billion. This makes Evolent Health the world's 3718th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $2.64 B | -30.33% |
2023 | $3.79 B | 33.63% |
2022 | $2.84 B | 14.85% |
2021 | $2.47 B | 82.95% |
2020 | $1.35 B | 76.64% |
2019 | $0.76 B | -51.53% |
2018 | $1.57 B | 71.94% |
2017 | $0.91 B | 18.05% |
2016 | $0.77 B | 54.86% |
2015 | $0.50 B |
On May 18th, 2024 the market cap of Evolent Health was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
National Healthcare
NHC | $1.54 B | -41.56% | ๐บ๐ธ USA |
Global Cord Blood CORBF | $0.16 B | -93.77% | ๐ญ๐ฐ Hong Kong |
Graham Holdings GHC | $3.38 B | 27.80% | ๐บ๐ธ USA |
CryoLife CRY | $0.70 B | -73.42% | ๐บ๐ธ USA |